论文信息 - Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia - 字舞流文

Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia

A. Vekhoff | D. DeAngelo | C. Dumontet | F. Giles | X. Thomas | O. Legrand | J. S. San Miguel | M. Vidriales | J. Lambert | S. Botton | R. Tang | S. Lapusan | J. Marie | R. Morariu-Zamfir | P. Poncelet | M. Ozoux